CM
GBT

Crestline Management’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Crestline Management’s Portfolio GBT Stock Details GBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-39,726
Closed -$1.27M – 306
2022
Q2 		$1.27M Buy
39,726
+4,431
+13% +$142K 0.17% 107
2022
Q1 		$1.22M Hold
35,295
– – 0.15% 124
2021
Q4 		$1.03M Buy
+35,295
New +$1.03M 0.08% 139